TY - JOUR
T1 - Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy
AU - Panzuto, F.
AU - Falconi, M.
AU - Nasoni, S.
AU - Angeletti, S.
AU - Moretti, A.
AU - Bezzi, M.
AU - Gualdi, G.
AU - Polettini, E.
AU - Sciuto, R.
AU - Festa, A.
AU - Scopinaro, F.
AU - Corleto, V. D.
AU - Bordi, C.
AU - Pederzoli, P.
AU - Delle Fave, G.
PY - 2003/4
Y1 - 2003/4
N2 - Background: In patients with digestive endocrine tumours, complete pre-operative staging is essential in planning proper management and evaluating treatment efficacy. To date, somatostatin receptor scintigraphy (SRS) is considered the 'gold standard' imaging procedure, and very few data are available concerning the use of helical computed tomography (hCT). This study aimed to determine the diagnostic accuracy and the ability to modify the surgical management of hCT, alone or combined with SRS. Patients and methods: Sixty patients were staged before surgery by hCT, SRS and tumour markers, and included in group 1 if suitable for radical surgery, otherwise in group 2. All patients underwent laparotomy followed by subsequent re-staging. Results: SRS sensitivity was 77%, 48% and 67% for primary, lymph-node and liver lesions, respectively. hCT sensitivity was 94%, 69% and 94% for primary, lymph-node and liver lesions, respectively (P = 0.02 versus SRS, for liver lesions). During pre-operative evaluation, hCT correctly staged 92% and SRS 75% of patients (P = 0.02). hCT provided additional information in 17% of patients. Conclusions: Since hCT has been shown to be extremely accurate, providing essential information for the planning of surgical treatment compared with that of SRS, both techniques should be used in the pre-operative work-up of digestive endocrine tumours.
AB - Background: In patients with digestive endocrine tumours, complete pre-operative staging is essential in planning proper management and evaluating treatment efficacy. To date, somatostatin receptor scintigraphy (SRS) is considered the 'gold standard' imaging procedure, and very few data are available concerning the use of helical computed tomography (hCT). This study aimed to determine the diagnostic accuracy and the ability to modify the surgical management of hCT, alone or combined with SRS. Patients and methods: Sixty patients were staged before surgery by hCT, SRS and tumour markers, and included in group 1 if suitable for radical surgery, otherwise in group 2. All patients underwent laparotomy followed by subsequent re-staging. Results: SRS sensitivity was 77%, 48% and 67% for primary, lymph-node and liver lesions, respectively. hCT sensitivity was 94%, 69% and 94% for primary, lymph-node and liver lesions, respectively (P = 0.02 versus SRS, for liver lesions). During pre-operative evaluation, hCT correctly staged 92% and SRS 75% of patients (P = 0.02). hCT provided additional information in 17% of patients. Conclusions: Since hCT has been shown to be extremely accurate, providing essential information for the planning of surgical treatment compared with that of SRS, both techniques should be used in the pre-operative work-up of digestive endocrine tumours.
KW - Digestive endocrine tumours
KW - Helical computed tomography
KW - Management
KW - Somatostatin receptor scintigraphy
KW - Staging
UR - http://www.scopus.com/inward/record.url?scp=0038157024&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0038157024&partnerID=8YFLogxK
U2 - 10.1093/annonc/mdg160
DO - 10.1093/annonc/mdg160
M3 - Article
C2 - 12649106
AN - SCOPUS:0038157024
VL - 14
SP - 586
EP - 591
JO - Annals of Oncology
JF - Annals of Oncology
SN - 0923-7534
IS - 4
ER -